Have you had a chance to explore our latest release?
To learn more about the updates, register for our webinar on 23 April!
The webinar is hosted by the European Bioinformatics Institute, register on their site: From variant to drug target: using the expanded Open Targets Platform to explore the genetics of target discovery | EMBL-EBI Training
The webinar will introduce the capabilities and use cases of the Open Targets Platform, including our new variant, study, and credible set pages. These allow you to dig deeper into the GWAS evidence for a target-disease association, explore our analyses of GWAS and molecular QTL studies, and relevant annotation data.
And if there are specific questions you’d like us to cover, let us know in the comments👇
See you there!